KMOV shares an InvestigateTV+ segment on the weight loss drug trend and what your insurance plan may or may not pay for. Details are in the full report.
Recap by typeshit. Post by KMOV on X.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
A Facebook post says Ozempic's Medicare price drops 71% as negotiated rates on 15 drugs, including Wegovy and Trelegy, take effect.
Negotiated Medicare prices on 15 drugs, Ozempic, Wegovy and Trelegy among them, take effect in 2027. The full list of drugs and discounts is at the link.
Maqubela's list of 2025 brand revenues puts Ozempic third at $19.2b, ahead of Dupixent and Skyrizi.
Matthew Mosk points to a CBS News investigation by Adam Yamaguchi, Laura Geller and Daniel Gilbert into a weight loss option. Tap through to see what they found.
Retatrutide has no FDA approval and is still being tested, yet CBS News says it is being advertised widely. Worth a look for anyone seeing those promos.
Loading…